Back to Search Start Over

FEIBA: A Prohemostatic Agent.

FEIBA: A Prohemostatic Agent.

Authors :
Caroline Cromwell
Louis Aledort
Source :
Seminars in Thrombosis & Hemostasis. Apr2012, Vol. 38 Issue 3, p265-267. 3p.
Publication Year :
2012

Abstract

Factor eight inhibitor bypassing activity (FEIBA), Anti-Inhibitor Coagulation Complex has been used for over 30 years in hemophiliac patients with inhibitors. The history of its use is reviewed here, including issues related to thrombosis, efficacy, and comparison to alternative bypassing agents. The need for surrogate assays to monitor effective hemostasis with the use of FEIBA remains. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00946176
Volume :
38
Issue :
3
Database :
Academic Search Index
Journal :
Seminars in Thrombosis & Hemostasis
Publication Type :
Academic Journal
Accession number :
74310983
Full Text :
https://doi.org/10.1055/s-0032-1309286